Medicamen Biotech Live Share Price Today, Share Analysis and Chart

Name: Medicamen Biotech Ltd.: Is Infosys Ltd. worth buying?
Item: Medicamen Biotech Ltd.
Rating: 2.820583375
Author: Trendlyne DVM scores

Mid-range Performer

about

Medicamen Biotech Limited (MBL) is an India-based pharmaceutical company primarily engaged in the development, manufacturing, and marketing of a wide range of generic pharmaceutical formulations. The company holds a significant position in both gener...

270.25 10.85 (4.18%)

39.63% Fall from 52W High

129.9K

NSE+BSE Volume

High volume today

NSE 04 Sep, 2026 3:31 PM (IST)

Dividend

Medicamen Biotech has an upcoming dividend of ₹1.000 per share due on 18 Sep 2026 See details

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

49.0 / 100

Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM

No estimates available

Medicamen Biotech Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Medicamen Biotech Ltd. worth buying?

40 Votes:

Buy 77.5%

Sell 17.5%

Hold 5.0%

Medicamen Biotech Live Share Price Today, Share Analysis and Chart

Medicamen Biotech Limited (MBL) is an India-based pharmaceutical company primarily engaged in the development, manufacturing, and marketing of a wide range of generic pharmaceutical formulations. The company holds a significant position in both gener...

39.63% Fall from 52W High

High volume today

SWOT Analysis

Medicamen Biotech Live Price Chart

Medicamen Biotech Live Price Chart